Nov 27 (Reuters) - Somnomed Ltd SOM.AX:
Q1 FY25 REVENUE AT A$25.3 MILLION, UP 18.2%
FY25 REVENUE GUIDANCE UPGRADED TO A$105 MILLION
APPOINTS YE-FEI GUO AS CFO
FY25 EBITDA GUIDANCE UPGRADED TO MORE THAN A$7 MILLION
Further company coverage: SOM.AX
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.